Calcidrine®

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.32.003.Е.003065.02.15
Date of registration and renewal:10.02.2015
Dosage form: & nbspPowder with a mass of 390 g
Classification "Composition" & nbsp Supplements - vitamins, vitamin-like substances and coenzymes
Classification "Clinical" & nbsp Supplements containing zinc, copper, manganese Supplements containing calcium and phosphorus Supplements containing potassium and magnesium Supplements containing iodine BAA containing fluorine
Composition: & nbspThe hydrolyzate is collagen, laktoglyukonat calcium, malic acid (E296), citric acid (E330), magnesium oxide, maltodextrin, derived from corn, vitamin C, vitamin E, zinc gluconate, aspartame (E951), manganese gluconate, copper gluconate, vitamin K1, vitamin D3, sodium monofluoride phosphate, potassium iodide, natural or nature-identical flavorings, dry the extracts of dandelion, horsetail, walnut
Scope: & nbspTo implement the public through pharmacies and specialty stores, department distribution network as a biologically active food additives (APP) additional collagen source, calcium, magnesium, zinc, manganese, copper, fluorine, iodine, vitamins C, E, D3, K1.
Suggested Usage: & nbspAdults 13 grams (1 scoop) dissolved in 200 ml of cold water, take 1 time a day at mealtime. Duration of admission is 2-3 months. Reception is recommended to be repeated 3 times a year.
Contraindications:Individual intolerance of components, pregnancy, lactation, phenylketonuria (contains phenylalanine).Before use, it is recommended to consult a doctor.
Shelf life:2 years.
Storage conditions:Store in a dry place inaccessible to children at a temperature of + 5 ° to 25 ° C.
Research protocols:In exchange for the certificate of state registration No.RU.77.99.11.003.E.041002.09.11 dated September 29, 2011, the expert opinion of the Research Institute for Nutrition of the RAMS No. 72 / E-690 / b-08 dated September 18, 2008, "TG and E in the Bryansk region" № 156 pn -1: 2П / 12.14 of 12/24/2014.
Recipient:Orling, Open CompanyOrling, Open Company Czech Republic
Information update date: & nbsp12.03.2017
Instructions
Up
talkdrugs

+8 (800)555-35-35

[email protected]

The reference book of medicines of the Publishing Group "GEOTAR-Media" - the leader in the field of professional medical and pharmaceutical literature.

The information on the preparations placed on the site is intended only for specialists. Drug descriptions can not be used by patients to make an independent decision on their use.

It is forbidden to copy any instructions of medicines,biologically active additives or other information from the site www.talkdrugs.info without the written permission of the Publishing House "GEOTAR".

All rights reserved. © Publishing group "GEOTAR-Media" 2008-2016.